On Nov. 7, 2019, the Vanderbilt-Ingram Cancer Center (VICC) announced its new role in the Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Consortium, a collaboration between the American Association for Cancer Research (AACR) and nine biopharmaceutical companies.